The Human Dimension: Putting the Person into Personalised Medicine.

about

The Human Dimension: Putting the Person into Personalised Medicine.

Item

http://www.wikidata.org/entity/Q53608049

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

The Human Dimension: Putting the Person into Personalised Medicine.

@en

The Human Dimension: Putting the Person into Personalised Medicine.

@nl

type

Item

label

The Human Dimension: Putting the Person into Personalised Medicine.

@en

The Human Dimension: Putting the Person into Personalised Medicine.

@nl

prefLabel

The Human Dimension: Putting the Person into Personalised Medicine.

@en

The Human Dimension: Putting the Person into Personalised Medicine.

@nl

P1476

The Human Dimension: Putting the Person into Personalised Medicine.

@en

P2093

Rob Horne

http://www.w3.org/2001/XMLSchema#string

P2860

Genetic risk and behavioural change

Understanding patients' adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the Necessity-Concerns Framework

Patient-reported side effects, concerns and adherence to corticosteroid treatment for asthma, and comparison with physician estimates of side-effect prevalence: a UK-wide, cross-sectional study.

Resisting medicines: a synthesis of qualitative studies of medicine taking.

A second life for eHealth: prospects for the use of 3-D virtual worlds in clinical psychology

Impact on decisions to start or continue medicines of providing information to patients about possible benefits and/or harms: a systematic review and meta-analysis.

No symptoms, no asthma: the acute episodic disease belief is associated with poor self-management among inner-city adults with persistent asthma.

Exploring chronic myeloid leukemia patients' reasons for not adhering to the oral anticancer drug imatinib as prescribed.

Adherence is the critical factor for achieving molecular responses in patients with chronic myeloid leukemia who achieve complete cytogenetic responses on imatinib.

The influence of symptom experiences and attributions on adherence to highly active anti-retroviral therapy (HAART): a six-month prospective, follow-up study.

P304

38-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/20502877.2017.1314894

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Rob Horne

P577

2017-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28517987

http://www.w3.org/2001/XMLSchema#string